Psychemedics Corporation Launches New Ketamine Hair Testing Service
29 August 2024 - 3:00PM
Psychemedics Corporation (NASDAQ: PMD), a global leader in hair
testing, is proud to announce the launch of its new ketamine hair
testing solution. This innovative testing method marks a
significant advancement in the detection and prevention for a
drug-free workplace and community.
Ketamine, a powerful dissociative anesthetic and emerging drug
of abuse, poses a growing concern for employers, educators, and law
enforcement agencies. With the introduction of this new testing
service, Psychemedics aims to equip organizations with the tools
needed to identify and address ketamine use effectively.
Key Features and Benefits of Ketamine Hair
Testing
- Long Detection Window: Unlike traditional drug
testing methods, hair analysis can detect ketamine use for up to 90
days, providing a comprehensive overview of an individual’s drug
use history.
- Non-Invasive and Convenient: The hair
collection process is simple and noninvasive and can be performed
without the need for specialized facilities, making it ideal for
various testing environments.
- High Sensitivity and Specificity: Utilizing
advanced technology, Psychemedics’ ketamine hair test ensures
highly accurate results, minimizing the risk of false positives and
negatives.
- Comprehensive Drug Panel: This new service can
be integrated into existing multi-drug panels offered by
Psychemedics, allowing for a broad-spectrum approach to drug
testing.
- Support for Various Industries: The ketamine
hair test is designed to meet the needs of diverse sectors,
including workplace safety programs, educational institutions,
rehabilitation centers, law enforcement agencies, and many
others.
“We are thrilled to introduce ketamine hair testing as part of
our commitment to delivering the most reliable and comprehensive
drug testing solutions,” said Brian Hullinger, CEO and President of
Psychemedics. “This new offering underscores our dedication to
innovation and our mission to support organizations in maintaining
safe and drug-free environments.”
Psychemedics’ ketamine hair testing service is now available to
clients and partners. For more information about this new service
or to schedule a consultation, please contact Psychemedics at
info@psychemedics.com or visit our website at
https://www.psychemedics.com.
About Psychemedics
Psychemedics Corporation is a leading global provider of
innovative hair testing for drugs of abuse. With a commitment to
accuracy and reliability, the company offers cutting-edge drug
testing solutions. Psychemedics Corporation is dedicated to
providing valuable insights and maintaining the highest standards
in substance abuse testing.
Investor Relations:Phone:
978-206-8220Email: InvestorRelations@psychemedics.com
Psychemedics (NASDAQ:PMD)
Historical Stock Chart
Von Dez 2024 bis Jan 2025
Psychemedics (NASDAQ:PMD)
Historical Stock Chart
Von Jan 2024 bis Jan 2025